WMSA
GTHX

Weiss Multi-Strategy Advisers’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,000
Closed -$435K – 679
2018
Q2 		$435K Buy
+10,000
New +$428K 0.01% 495

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GTHX Position: Q3 2018 in Review

Weiss Multi-Strategy Advisers sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2018, closing a stake of 10,000 shares — an estimated $435K sold.

Weiss Multi-Strategy Advisers first reported a position in GTHX in Q2 2018 and held it in 1 quarter. The position peaked at $435K in Q2 2018. 115 funds tracked by Wall St. Rank hold GTHX as of Q3 2018.

  • Weiss Multi-Strategy Advisers reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 10,000 G1 Therapeutics, Inc. Common Stock shares in Q3 2018, an estimated $435K.
  • Weiss Multi-Strategy Advisers first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's G1 Therapeutics, Inc. Common Stock position peaked at $435K in Q2 2018.
  • 115 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.